DOUGLAS CHARLES MACLELLAN

CIK 1200827 · Chief Executive Officer · last filed 2022-05-27

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$9.1K

Companies

3

Total Filings

32

Lifetime Open-Market Net

-$45.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CNET Director 0 $1.04 $0 $0 3 2015-04-21
RPC Director 1,100 $8.28 $9.1K $0 1 2009-10-19
RADIENT PHARMACEUTICALS Corp (ADL) Delisted Chief Executive Officer 201,100 -$45.0K 5 2009-01-09

Recent Filings · Page 2 of 4

32 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-01-11 Sell (S) −40,000 -$46.7K
2021-01-07 Sell (S) −40,000 -$38.4K
2020-12-15 Grant (A) +1,000,000 $0
2020-06-12 Sell (S) −10,000 -$1.0K
2020-06-11 Grant (A) +10,000 $970
2020-03-02 Grant (A) +3,000,000 $0
2019-02-20 Grant (A) +2,000,000 $0
2018-10-15 Grant (A) +4,200,000 $0
2015-09-30 Grant (A) +50,000 $0
2015-05-19 Grant (A) +50,000 $0
Showing 1120 of 32
Page 2 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.